Numerous studies have shown that the quantity of Th17 cells and IL-17 is elevated in the blood and cerebrospinal fluid (CSF) of patients with MS and is positively associated with disease activity and relapse frequency [46, 47]. The gene discussed is IL17A; the disease is myeloid sarcoma.